Rice Anthocyanin Bioavailability in Humans
Anthocyanin Bioavailability and Plasma Antioxidant Capacity in Healthy Volunteers After Acute Rice Intake
1 other identifier
interventional
20
1 country
1
Brief Summary
Aims of the project
- 1.To determine the rice anthocyanin content via high-performance liquid chromatographycoupled to mass spectrometry, HPLC-MS
- 2.To study the oral bioavailability of anthocyanins in healthy volunteers after the intake of a serving (80 g) of black rice (Venere and Artemide varieties).
- 3.To determine the plasma biokinetics parameters of rice anthocyanins via spectrophometric determination and high-performance liquid chromatographycoupled to mass spectrometry, HPLC-MS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Mar 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 6, 2019
CompletedFirst Submitted
Initial submission to the registry
April 17, 2019
CompletedFirst Posted
Study publicly available on registry
May 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 21, 2019
CompletedApril 3, 2020
April 1, 2020
2 months
April 17, 2019
April 2, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Changes in plasma total anthocyanin detection
Total anthocyanins will be detected via spectrophometric determination; expressed as μg of catechin per mL of plasma
0.0 (baseline, before starting the intervention), then after 0.5 hour, 1 hour, 2 hours and 3 hours
Changes in plasma Cyanidin-3-O-glucoside detection
Cyanidin-3-O-glucoside will be detected via high-performance liquid chromatographycoupled to mass spectrometry, HPLC-MS) in plasma; expressed nM (nano molar) in plasma
0.0 (baseline, before starting the intervention), then after 0.5 hour, 1 hour, 2 hours and 3 hours
Secondary Outcomes (2)
Changes in plasma antioxidant capacity ABTS
0.0 (baseline, before starting the intervention), then after 0.5 hour, 1 hour, 2 hours and 3 hours
Changes in plasma antioxidant capacity DPPH
0.0 (baseline, before starting the intervention), then after 0.5 hour, 1 hour, 2 hours and 3 hours
Study Arms (3)
Black rice Venere
EXPERIMENTALHealthy volunteers will receive the black rice Venere in a cross-over randomized clinical trial (after 7 days wash-out).
Black rice Artemide
EXPERIMENTALHealthy volunteers will receive the black rice Artemide in a cross-over randomized clinical trial (after 7 days wash-out).
Complete white rice
SHAM COMPARATORHealthy volunteers will receive the complete white rice in a cross-over randomized clinical trial (after 7 days wash-out).
Interventions
Each group will randomly receive, during three different experimental days, one of the following treatments by different allocation sequences: 1. 80g of black rice Venere (Group A) 2. 80g of black rice Artemide (Group B) 3. 80g of brown rice (Group C) The three treatments will be separated by a 7 day wash-out period. After an overnight fast, volunteers will consume the rice serving within 10-15 min, immediately after the first basal blood collection at 8:00 a.m. (baseline). Other blood withdrawals will be carried out a 0.5, 1.0, 2.0 and 3.0 h after rice administration.
Eligibility Criteria
You may qualify if:
- Healthy status
- Age: 18-45
- Normal weight (BMI 18.5-24.9) who voluntarily accept to join the study, after informed consent.
You may not qualify if:
- \<18 Years;
- Pregnancy and lactation;
- Systemic disorders;
- Dietary supplements intake (vitamins, antioxidants, botanicals, phytochemicals)
- Abnormal hematological parameters;
- Heavy smoking and alcohol drinking;
- High-intensity physical activity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marcello Iriti
Milan, MI, 20133, Italy
Related Publications (5)
Garcia-Conesa MT, Chambers K, Combet E, Pinto P, Garcia-Aloy M, Andres-Lacueva C, de Pascual-Teresa S, Mena P, Konic Ristic A, Hollands WJ, Kroon PA, Rodriguez-Mateos A, Istas G, Kontogiorgis CA, Rai DK, Gibney ER, Morand C, Espin JC, Gonzalez-Sarrias A. Meta-Analysis of the Effects of Foods and Derived Products Containing Ellagitannins and Anthocyanins on Cardiometabolic Biomarkers: Analysis of Factors Influencing Variability of the Individual Responses. Int J Mol Sci. 2018 Feb 28;19(3):694. doi: 10.3390/ijms19030694.
PMID: 29495642BACKGROUNDKrga I, Milenkovic D. Anthocyanins: From Sources and Bioavailability to Cardiovascular-Health Benefits and Molecular Mechanisms of Action. J Agric Food Chem. 2019 Feb 20;67(7):1771-1783. doi: 10.1021/acs.jafc.8b06737. Epub 2019 Feb 8.
PMID: 30698008BACKGROUNDCiulu M, Cadiz-Gurrea ML, Segura-Carretero A. Extraction and Analysis of Phenolic Compounds in Rice: A Review. Molecules. 2018 Nov 6;23(11):2890. doi: 10.3390/molecules23112890.
PMID: 30404149BACKGROUNDDias ALS, Pachikian B, Larondelle Y, Quetin-Leclercq J. Recent advances on bioactivities of black rice. Curr Opin Clin Nutr Metab Care. 2017 Nov;20(6):470-476. doi: 10.1097/MCO.0000000000000417.
PMID: 28858891BACKGROUNDVan Hung P. Phenolic Compounds of Cereals and Their Antioxidant Capacity. Crit Rev Food Sci Nutr. 2016;56(1):25-35. doi: 10.1080/10408398.2012.708909.
PMID: 25075608BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Marcello Iriti
University of Milan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 17, 2019
First Posted
May 2, 2019
Study Start
March 6, 2019
Primary Completion
May 15, 2019
Study Completion
July 21, 2019
Last Updated
April 3, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share